Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q421042> ?p ?o }
Showing triples 1 to 53 of
53
with 100 triples per page.
- Q421042 subject Q5920511.
- Q421042 subject Q7071513.
- Q421042 subject Q8221192.
- Q421042 subject Q8248726.
- Q421042 subject Q8376909.
- Q421042 subject Q8808791.
- Q421042 abstract "Vildagliptin (previously LAF237, trade names Galvus, Zomelis,) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus.Vildagliptin is a unique molecule with dual nature as it manages the glucagon levels in hypoglycemia as well as hyperglycemia.".
- Q421042 atcPrefix "A10".
- Q421042 atcSuffix "BH02".
- Q421042 atcSupplemental "(withmetformin)".
- Q421042 bioavailability "85.0".
- Q421042 casNumber "274901-16-5".
- Q421042 drugbank "DB04876".
- Q421042 fdaUniiCode "I6B4B2U96P".
- Q421042 iupacName "(S)-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile".
- Q421042 pubchem "6918537".
- Q421042 thumbnail Vildagliptin.svg?width=300.
- Q421042 wikiPageExternalLink cx_mh_rl_diabetestearsheet_5.html.
- Q421042 wikiPageExternalLink merck-novartis-januvia-pf-ii-in_dk_0302soapbox_inl.html.
- Q421042 wikiPageWikiLink Q103135.
- Q421042 wikiPageWikiLink Q130146.
- Q421042 wikiPageWikiLink Q14904803.
- Q421042 wikiPageWikiLink Q19484.
- Q421042 wikiPageWikiLink Q3025883.
- Q421042 wikiPageWikiLink Q407693.
- Q421042 wikiPageWikiLink Q419770.
- Q421042 wikiPageWikiLink Q419977.
- Q421042 wikiPageWikiLink Q424611.
- Q421042 wikiPageWikiLink Q5266764.
- Q421042 wikiPageWikiLink Q575062.
- Q421042 wikiPageWikiLink Q5920511.
- Q421042 wikiPageWikiLink Q7071513.
- Q421042 wikiPageWikiLink Q8221192.
- Q421042 wikiPageWikiLink Q8248726.
- Q421042 wikiPageWikiLink Q8376909.
- Q421042 wikiPageWikiLink Q8808791.
- Q421042 wikiPageWikiLink Q9377.
- Q421042 atcPrefix "A10".
- Q421042 atcSuffix "BH02".
- Q421042 bioavailability "85.0".
- Q421042 casNumber "274901".
- Q421042 drugbank "DB04876".
- Q421042 iupacName "-1".
- Q421042 pubchem "6918537".
- Q421042 unii "I6B4B2U96P".
- Q421042 type ChemicalSubstance.
- Q421042 type Drug.
- Q421042 type ChemicalObject.
- Q421042 type Thing.
- Q421042 type Q8386.
- Q421042 comment "Vildagliptin (previously LAF237, trade names Galvus, Zomelis,) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.".
- Q421042 label "Vildagliptin".
- Q421042 depiction Vildagliptin.svg.
